Eve Maubec
Bobigny, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Efficacy and safety of anti-PD-1 plus lenvatinib in mucosal melanoma: a real-world series.
Journal: Annales de dermatologie et de venereologie
Published: October 23, 2025
Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 22, 2025
Avelumab plus cetuximab in advanced cutaneous squamous cell carcinoma: a strategy to overcome resistance to PD-1 blockade.
Journal: The British journal of dermatology
Published: August 17, 2025
Open data: main objective achieved for the French Society of Pathology's data challenges
Journal: Annales de pathologie
Published: June 09, 2025
Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.
Journal: EClinicalMedicine
Published: December 25, 2024
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: a nationwide real-life study in France (NEOMEL).
Journal: The British journal of dermatology
Published: December 10, 2024
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort.
Journal: Melanoma research
Published: November 11, 2024
Understanding kidney involvement in mycosis fungoides: T-cell clonality as a guide for targeted therapy - a case report and literature review.
Journal: BMC nephrology
Published: October 25, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting.
Journal: The British journal of dermatology
Published: July 17, 2024
Last Updated: 09/26/2026